• Papers

  more

• [1] 1. Xinyue Wang#, Ning Li#*, Lu Han#, Ou Qiao#, Xin Chen, Pengtao Wang, Lancao Zhang, Yingjie Hou, Fengjiao Bao, Herui Hao, Saeed Sania, Li Zhang1, Zizheng Li, Xiaohong Duan, Shuquan Rao*, Zichuan Liu*,Yanhua Gong*，Rescue RM/CS-AKI by blocking strategy with one-dose anti-myoglobin RabMAb, Nature Communications, 2025 Jan 26;16(1):1044. doi: 10.1038/s41467-025-56353-4;
• [2] 2. Ning Li#, Zhang Li#, Xinyue Wang, Xu Lin Yan，Yanhua Gong*，Special Contribution of Atomic Force Microscopy in Cell Death Research，Nanotechnology Reviews，2024，13（1）: 20230208，DOI:10.1515/ntrev-2023-0208;
• • [3] 3. Ou Qiao, Li Zhang, Lu Han, Xinyue Wang, Zizheng Li, Fengjiao Bao, Herui Hao, Yingjie Hou, Xiaohong Duan, Ning Li*, Yanhua Gong*, Rosmarinic acid plus deferasirox inhibits ferroptosis to alleviate crush syndrome-related AKI via Nrf2/Keap1 pathway, Phytomedicine，2024,129. DOI:10.1016/j.phymed.2024.155700;
  • [4] 4. Ou Qiao#, Xinyue Wang#, Zizheng Li, Lu Han, Xin Chen, Li Zhang, Fengjiao Bao, Herui Hao, Yingjie Hou, Xiaohong Duan, Sania Saeed, Ning Li* and Yanhua Gong*. Paving the Way Ahead: Protocol Optimization of Mouse Models in Crush Syndrome Related Acute Kidney Injury Research, Frontiers in Pharmacology , 2024， 30:15:1438127. DOI:10.3389/fphar.2024.1438127;
  • [5] 5. Zizheng Li#, Ou Qiao#, Yuru Wang , Ning Li*, Yanhua Gong*，Potential therapeutic targets for trauma management，Trends in Pharmacological Sciences，2023;44(12):891-901;
  • [6] 6. Ning Li#, Xinyue Wang#, Yuru Wang, Pengtao Wang, Na Sun, Jiale Chen, Lu Han, Zizheng Li, Haojun Fan, Yanhua Gong* , Delayed step-by-step decompression with DSF alleviates skeletal muscle crush injury by inhibiting NLRP3/CASP-1/GSDMD pathway, Cell Death Discovery, 2023 Aug 1;9(1):280. DOI:10.1038/s41420-023-01570-3;
  • [7] 7. Ning Li#; Lu Han#; Xinyue Wang; Ou Qiao; Li Zhang; Yanhua Gong*; Biotherapy of experimental acute kidney injury: emerging novel therapeutic strategies, Translational Research, 2023 Jun 15;(1-17).doi:10.1016/j.trsl.2023.06.002;
  • [8] 8. Chenhao Geng #, Xinyue Wang#, Na Sun, Jiale Chen, Yuru Wang, Zizheng Li, Lu Han, Shike Hou, Haojun Fan, Ning Li *, Yanhua Gong*,Repetitive Low-Level Blast Exposure via Akt/NF-κB Signaling Pathway Mediate the M1 Polarization of Mouse Alveolar Macrophage MH-S Cells, International Journal of Molecular Sciences, 2023, Jun 25;24(13):10596. DOI:10.3390/ijms241310596;
  • [9] 9. Ou Qiao#; Xinyue Wang#; Yuru Wang; Ning Li*; Yanhua Gong*; Ferroptosis in acute kidney injury following crush syndrome: a novel target for treatment, Journal of Advanced Research,2023 Jan 23; S2090-1232(23)00029-2. doi: 10.1016/j.jare.2023.01.016;
  • [10] 10. Xinyue Wang#; Ou Qiao#; Lu Han; Ning Li*; Yanhua Gong*;A novel rabbit anti-myoglobin monoclonal antibody's application in rhabdomyolysis associated AKI, International Journal of Molecular Sciences, 2023, 24, 7822. DOI:10.3390/ijms24097822;
  • [11] 11. Ning Li; Yuru Wang; Xinyue Wang; Na Suna; Yanhua Gong*; Pathway network of pyroptosis and its potential inhibitors in acute kidney injury, Pharmacological Research, 2022, 175: 106033;
  • [12] 12. Ning Li; Jiale Chen; Chenhao Geng; Xinyue Wang; Yuru Wang; Na Sun; Pengtao Wang; Lu Han;Zizheng Li; Haojun Fan; Shike Hou*; Yanhua Gong*; Myoglobin promotes macrophage polarization to M1type and pyroptosis via the RIG-I/Caspase1/GSDMD signaling pathway in CS-AKI, Cell Death Discovery, 2022, 8(90)
  • [13] 13. Pengtao Wang; Ning Li; Xinyue Wang; Jiale Chen; Chenhao Geng; Ziquan Liu; Haojun Fan; Qi Lv; Shike Hou*; Yanhua Gong*; RIG-I, a novel DAMPs sensor for myoglobin, activates NF-κB/caspase-3 signaling in CS-AKI model, Military Medical Research, 2021, 8(37);
  • [14] 14. Ning Li; Xinyue Wang; Pengtao Wang; Haojun Fan; Shike Hou*; Yanhua Gong*; Emerging medical therapies in crush syndrome-progress report from basic sciences and potential future avenues, Renal Failure, 2020, 42(1): 656-666;
  • [15] 15. Ning Li; Chenhao Geng; Shike Hou; Haojun Fan*; Yanhua Gong*; Damage-Associated Molecular Patterns and Their Signaling Pathways in Primary Blast Lung Injury: New Research Progress and Future Direction, International Journal of Molecular Sciences, 2020, 21: 6303;

• Honors & Awards

  more

• [1] 1、国家自然科学基金面上项目，82273998，利用单克隆中和抗体靶向Mb肾毒性早期救治CS-AKI的药理机制研究，2023 /01- 2026 /12 ，52万，在研，主持；
• [2] 2、国家重点研发计划项目, 2021YFC3002203, 挤压综合征多器官损伤机制与早期控制新技术研究（子课题）, 2021/12 -2024/11, 151万元, 结题, 主持；
• • [3] 3、国家重点研发计划项目，2019YFC1606304，突发重特大自然灾害事件食品安全应急保障技术体系集成与应用（课题），2019 /12- 2022 /12，1826万（国拨经费326万），已结题，主持；
  • [4] 4、天津大学“双一流大学”人才启动金，挤压综合征急性肾损伤的机制与生物救治研究，2019/01-2020/12，80万，已结题，主持；
  • [5] 5、中央军委科技委创新项目，XXXX综合征快速诊断与生物治疗，C12019048, 2019/06-2020/12，200万，已结题，子课题负责人；
  • [6] 6、科研项目，WJHQ2012-13，NSPc1在部队作业辐射损伤过程中对机体保护作用的机制研究，2013/01-2015/12，18万元，已结题，主持；
  • [7] 7、国家自然科学基金面上项目，31070929，NSPc1调控小鼠神经干细胞体外增殖与分化的分子机制，2011/01-2013/12，34万元，已结题，主持；
  • [8] 8、国家自然科学基金项目（主任基金），30971614，干细胞中表观抑制因子NSPc1 的调控作用，2010/01-2010/12，8万元，已结题，主持；
  • [9] 9、国家自然科学基金青年项目，30600166，神经系统多梳蛋白NSPc1抑制转录与促细胞增殖的表观调控机制，2007/01-2009/12，30万元，已结题，主持；
  • [10] 10、国家科技部863计划项目，2006AA02Z137，神经肿瘤细胞分化相关蛋白网络调控节点的识别和筛选，2006/12-2008/12，90万元，已结题，主持；
  • [11] 11、国家科技部973计划，2006CB504100，高原低氧等环境因素损伤适应机理与干预措施，2006/09-2011/09，50万元，已结题，子课题负责人；